0000
Dongwha Pharm.Co.,Ltd (000020)
Market Closed
24 Dec, 06:30
KRX SM KRX SM Primary 
SSE ₩
6,460. 00
+130
+2.05%
₩
174.35B Market Cap
- P/E Ratio
- Div Yield
36,534 Volume
0 Eps
₩ 6.33K
Previous Close Day Range
6,330 6,460
Year Range
5,950 10,760
Want to track 000020 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
000020 Chart
Dongwha Pharm.Co.,Ltd Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Doh Joon Yoon CEO | KRX SM Exchange | KR7000020008 ISIN |
| KR Country | - Employees | - Last Dividend | 2 Jul 2009 Last Split | - IPO Date |
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.
Contact Information
Address: FastFive Tower, Seoul, South Korea, 04522
Phone: 82 2 2021 9300
Website: https://www.dong-wha.co.kr
2024 © Marketlog. All Rights Reserved.
